NR 601 Midterm
Influenza inactive (IIV), or recombinant (RIV) - ANS-1 dose annually
Tetanus, diphtheria, pertussis (TDAP) - ANS-1 dose after age 65 years then TDAP
every 10 years
Varicella recombinant (Shingrix) - ANS-2 doses 2-5 months apart. Give to those who
had zoster. at age 50 or older
Pneumococcal - ANS-At 65 years. 1 dose of PPSV23 (Polysaccharide, Pneumovax);
consider 1 dose PCV 13 in high-risk patients
Hepatitis A/hepatitis B - ANS-Only if high risk, and at least once
Lipid panel - ANS-Every 5 years
Influenza inactive (IIV), or recombinant (RIV) - ANS-1 dose annually
Tetanus, diphtheria, pertussis (TDAP) - ANS-1 dose after age 65 years then TDAP
every 10 years
Varicella recombinant (Shingrix) - ANS-2 doses 2-5 months apart. Give to those who
had zoster. at age 50 or older
Pneumococcal - ANS-At 65 years. 1 dose of PPSV23 (Polysaccharide, Pneumovax);
consider 1 dose PCV 13 in high-risk patients
Hepatitis A/hepatitis B - ANS-Only if high risk, and at least once
Lipid panel - ANS-Every 5 years